Northwestern Mutual Wealth Management’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-500	Closed	-$3.94K	–	3714
2023 Q1	$3.94K	Hold	500	–	–	﹤0.01%	2810
2022 Q4	$450	Hold	500	–	–	﹤0.01%	3139
2022 Q3	$1K	Hold	500	–	–	﹤0.01%	3061
2022 Q2	$1K	Hold	500	–	–	﹤0.01%	3130
2022 Q1	$1K	Hold	500	–	–	﹤0.01%	3063
2021 Q4	$2K	Hold	500	–	–	﹤0.01%	2986
2021 Q3	$2K	Buy	+500	New	+$2.08K	﹤0.01%	2884

Other funds holding BLPH

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northwestern Mutual Wealth Management's BLPH Position: Q2 2023 in Review

Northwestern Mutual Wealth Management sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q2 2023, closing a stake of 500 shares — an estimated $3.94K sold.

Northwestern Mutual Wealth Management first reported a position in BLPH in Q3 2021 and held it in 7 quarters. The position peaked at $3.94K in Q1 2023. 23 funds tracked by Wall St. Rank hold BLPH as of Q2 2023.

Northwestern Mutual Wealth Management reported no remaining Bellerophon Therapeutics, Inc. position as of Q2 2023 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 500 Bellerophon Therapeutics, Inc. shares in Q2 2023, an estimated $3.94K.
Northwestern Mutual Wealth Management first reported a position in Bellerophon Therapeutics, Inc. in Q3 2021 and held it in 7 quarters.
Northwestern Mutual Wealth Management's Bellerophon Therapeutics, Inc. position peaked at $3.94K in Q1 2023.
23 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q2 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2023, filed 14 Aug 2023.